Dear readers! We are pleased to present you the sixth issue of the LOGISTICS magazine in 2025, which contains a lot of relevant materials. In the latest issue, our permanent partner COMITAS company presents an innovative solution dictated by the shortage of warehouse space and difficulties with personnel selection – the high-rise automated self-supporting "COMITAS Warehouse".
Dear readers! The first half of the year is approaching, which means that on the pages of the fifth issue of the magazine you will find a lot of useful analytical materials on the markets of warehouse real estate, cargo transportation, etc. Our authors Yu.V. Klimenko, M.G. Grigoryan, R.N.
Dear readers! We present to your attention the fourth issue of the LOGISTICS journal. By tradition, in the April issue we summarize the results of TransRussia | SkladTech 2025. This year, the exhibition attracted a record number of exhibitors and over 30,000 visitors. Under the heading "non-economic activity", we are posting an interesting article by A.V. Efimov on the prospects for the development of non-primary non-energy exports from Russia to Vietnam.
Irvine, CA, August 25, 2015 – MNX Global Logistics announces the opening of its dedicated supply chain and logistics facility in Amsterdam, the Netherlands, located just outside of Amsterdam Airport Schiphol. This facility with validated temperature-controlled supply chain capabilities will serve as the operations and warehousing hub for our Life Sciences and Medical Device customers throughout Europe.
“The demand for our services particularly in biologics, cold chain and medical devices logistics in the EMEA region has been tremendous and we have seen double digit growth in the past 12 months,” said Paul J. Martins, MNX CEO and President. “Customers with the need for expertise in regulatory transport, strict adherence to chain of custody, visibility, control and security of their high value and time critical products are turning more and more to MNX. Our investment in this new facility in Amsterdam is testament to MNX and our private equity partner, The Riverside Company’s commitment to meet the needs and exceed the expectations of our customers.”
The new facility’s capacity exceeds 1300 sq. m with the option to expand by an additional 1700 sq. m when needed. The HACCP and GDP compliant facility was designed to exceed the highest standards in the handling and movement of critical biopharmaceutical, radiopharmaceutical and medical device shipments. The facility features -20 degrees C, 2-8 degrees C and 18 degrees C temperature controlled storage with 24/7 monitoring, back-up systems and state of the art security in order to ensure the constant integrity and security of our customer’s temperature and high value shipments.
“The new Life Sciences Logistics Centre in Amsterdam allows us to provide cross docking, inventory storage and transportation for our clients needing temperature sensitive control,” said Jan Willem Van ‘t Riet, MNX Senior Vice President for EMEA. “In addition, our customers will benefit from our strict adherence to industry wide compliance procedures and protocols and our direct ramp access to personally deliver and retrieve critical shipments from the airlines that serve Amsterdam Airport Schiphol.”
Utilizing our own dedicated GDP compliant facility at Amsterdam allows MNX to provide on-site highly qualified and trained staff, with the ability to comply with the strictest standards for packaging, inventory, cross dock, storage and transportation for our customer’s shipments.